Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00804024 · ClinicalTrials.gov registry record

ClearWay™ RX Registry Trial

A clinical trial, sponsored by Atrium Medical Corporation.

Completed
Registry status
102
Enrollment target

NCT00804024 is a clinical trial that has completed, run by Atrium Medical Corporation. The registered enrollment target is 102 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00804024 has completed, sponsored by Atrium Medical Corporation.

COMPLETED
Registry status
102 participants
Enrollment target

Study Summary

The primary goal of this registry is to collect data regarding the use of the ClearWay RX Local Therapeutic Infusion Catheter for all indications.

Interventions

  • DEVICE ClearWay™ RX Local Therapeutic Infusion Catheter

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2008-08
Est. Completion 2010-10

Sponsor

Atrium Medical Corporation

5 total trials

What the Registry Record Tells You About NCT00804024

The ClinicalTrials.gov registry entry for NCT00804024 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Atrium Medical Corporation, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which ClearWay™ RX Local Therapeutic Infusion Catheter is the first listed.

NCT00804024 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00804024 about?

NCT00804024 is a clinical study titled "ClearWay™ RX Registry Trial". The primary goal of this registry is to collect data regarding the use of the ClearWay RX Local Therapeutic Infusion Catheter for all indications.

What is the current status of trial NCT00804024?

This trial is currently completed. The enrollment target is 102 participants. The study started on 2008-08. Estimated completion is 2010-10.

What interventions are being tested in trial NCT00804024?

The interventions under investigation include: ClearWay™ RX Local Therapeutic Infusion Catheter (DEVICE).

Who is sponsoring clinical trial NCT00804024?

This trial is sponsored by Atrium Medical Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.